1. Home
  2. BHVN vs AMTM Comparison

BHVN vs AMTM Comparison

Compare BHVN & AMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • AMTM
  • Stock Information
  • Founded
  • BHVN 2013
  • AMTM 2020
  • Country
  • BHVN United States
  • AMTM United States
  • Employees
  • BHVN N/A
  • AMTM N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • AMTM
  • Sector
  • BHVN Health Care
  • AMTM
  • Exchange
  • BHVN Nasdaq
  • AMTM NYSE
  • Market Cap
  • BHVN 5.4B
  • AMTM 6.1B
  • IPO Year
  • BHVN 2017
  • AMTM N/A
  • Fundamental
  • Price
  • BHVN $45.17
  • AMTM $24.80
  • Analyst Decision
  • BHVN Strong Buy
  • AMTM Strong Buy
  • Analyst Count
  • BHVN 13
  • AMTM 2
  • Target Price
  • BHVN $63.42
  • AMTM $30.50
  • AVG Volume (30 Days)
  • BHVN 729.5K
  • AMTM 1.7M
  • Earning Date
  • BHVN 11-12-2024
  • AMTM 12-17-2024
  • Dividend Yield
  • BHVN N/A
  • AMTM N/A
  • EPS Growth
  • BHVN N/A
  • AMTM N/A
  • EPS
  • BHVN N/A
  • AMTM N/A
  • Revenue
  • BHVN N/A
  • AMTM $5,616,000,000.00
  • Revenue This Year
  • BHVN N/A
  • AMTM N/A
  • Revenue Next Year
  • BHVN $179.00
  • AMTM N/A
  • P/E Ratio
  • BHVN N/A
  • AMTM $21.22
  • Revenue Growth
  • BHVN N/A
  • AMTM 8.35
  • 52 Week Low
  • BHVN $26.80
  • AMTM $21.24
  • 52 Week High
  • BHVN $62.21
  • AMTM $34.50
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 38.20
  • AMTM N/A
  • Support Level
  • BHVN $43.18
  • AMTM N/A
  • Resistance Level
  • BHVN $54.53
  • AMTM N/A
  • Average True Range (ATR)
  • BHVN 2.57
  • AMTM 0.00
  • MACD
  • BHVN -0.85
  • AMTM 0.00
  • Stochastic Oscillator
  • BHVN 16.86
  • AMTM 0.00

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About AMTM AMENTUM HOLDINGS INC

Amentum Holdings Inc is a global leader in advanced engineering and innovative technology solutions. It is trusted by the United States and its allies to address their most significant and complex challenges in science, security, and sustainability.

Share on Social Networks: